caffeine has been researched along with Chronic Illness in 97 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "A double-blind, randomized, multicenter investigation was conducted to compare the efficacy and safety of Fioricet, acetaminophen with codeine, and placebo for the symptomatic treatment of tension headache." | 9.06 | Symptomatic treatment of chronically recurring tension headache: a placebo-controlled, multicenter investigation of Fioricet and acetaminophen with codeine. ( DiSerio, FJ; Friedman, AP, 1987) |
| "Caffeine dependence is a frequent cause of chronic daily headache." | 7.71 | [Chronic daily headaches caused by too much caffeine]. ( Schonewille, WJ, 2002) |
| "Our findings indicate that dietary caffeine consumption is not related to the global experience of pain and disability in patients with chronic low back pain, although high caffeine use may be embedded in a context of other unhealthy life-style behaviors." | 7.69 | Caffeine and chronic low back pain. ( Currie, SR; Gauthier, ST; Wilson, KG, 1995) |
| "In a pain management program (200 patients), a group of daily users of oxycodone compound (29 patients) and a subgroup who were taking a "high dose" of oxycodone compound (13 patients) were compared with a group of 171 non-users of oxycodone compound." | 7.66 | Problems with the use of oxycodone compound in patients with chronic pain. ( Maruta, T; Swanson, DW, 1981) |
| "The patients with liver cirrhosis were classified according to the Child--Pugh scoring system." | 6.68 | [Diagnostic value of the study of caffeine elimination in chronic liver diseases]. ( Bariska, J; Darnót, G; Nemesánszky, E, 1995) |
| "Chronic neuroinflammation is associated with an increase in extracellular levels of glutamate and drugs that limit the effects of glutamate at neuronal receptors have been shown to indirectly reduce the neuroinflammatory response of microglia cells." | 5.36 | Caffeine attenuates lipopolysaccharide-induced neuroinflammation. ( Brothers, HM; Marchalant, Y; Wenk, GL, 2010) |
| "Patients with moderate to severe chronic plaque psoriasis (n = 21) received single oral doses of sensitive probe substrates for CYP1A2 (caffeine 100 mg), CYP2C9 (warfarin 10 mg), CYP2C19 (omeprazole 20 mg), CYP2D6 (metoprolol 50 mg), and CYP3A (midazolam 2 mg) on day 1, followed by 12 weeks of subcutaneous risankizumab treatment of 150 mg once every 4 weeks from day 8 to day 92, and again the same cocktail of substrates on day 98." | 5.30 | Lack of Effect of 12-Week Treatment with Risankizumab on the Pharmacokinetics of Cytochrome P450 Probe Substrates in Patients with Moderate to Severe Chronic Plaque Psoriasis. ( Camez, A; Cheng, L; Ignatenko, S; Khatri, A; Othman, AA; Pang, Y, 2019) |
| "A double-blind, randomized, multicenter investigation was conducted to compare the efficacy and safety of Fioricet, acetaminophen with codeine, and placebo for the symptomatic treatment of tension headache." | 5.06 | Symptomatic treatment of chronically recurring tension headache: a placebo-controlled, multicenter investigation of Fioricet and acetaminophen with codeine. ( DiSerio, FJ; Friedman, AP, 1987) |
| "Potentially remediable risk factors include frequency of migraine attacks, obesity, excessive use of medications containing opioids and barbiturates, caffeine overuse, stressful life events, depression, sleep disorders and cutaneous allodynia." | 4.85 | What predicts the change from episodic to chronic migraine? ( Bigal, ME; Lipton, RB, 2009) |
| " Herein, we have investigated the significance of adenosine, through the blockade of its receptors with caffeine, on the CB hypoxic sensitization induced by chronic intermittent hypoxia (CIH) in the rat." | 3.81 | Adenosine Receptor Blockade by Caffeine Inhibits Carotid Sinus Nerve Chemosensory Activity in Chronic Intermittent Hypoxic Animals. ( Conde, SV; Gonzalez, C; Gonzalez-Martin, MC; Sacramento, JF, 2015) |
| "Caffeine dependence is a frequent cause of chronic daily headache." | 3.71 | [Chronic daily headaches caused by too much caffeine]. ( Schonewille, WJ, 2002) |
| "Our findings indicate that dietary caffeine consumption is not related to the global experience of pain and disability in patients with chronic low back pain, although high caffeine use may be embedded in a context of other unhealthy life-style behaviors." | 3.69 | Caffeine and chronic low back pain. ( Currie, SR; Gauthier, ST; Wilson, KG, 1995) |
| "In spite of clinical differences between transformed migraine and tension headache, which may help diagnosis, in our series abuse of analgesics (including ergotamine) was a common characteristic." | 3.69 | [Clinical features of daily chronic headache]. ( Iñiguez, C; Larrodé, P; Mauri, JA; Morales, F, 1997) |
| "In the course of evaluating the acute effect of caffeine-containing coffee on the risk of myocardial infarction (MI) among women 30-49 years of age, this study noted appreciable differences in coffee consumption among hospital patients admitted for illnesses not known to be related to coffee use." | 3.66 | Case-control studies on the acute effects of coffee upon the risk of myocardial infarction: problems in the selection of a hospital control series. ( Kaufman, DW; Miettinen, OS; Rosenberg, L; Shapiro, S; Slone, D, 1981) |
| "In a pain management program (200 patients), a group of daily users of oxycodone compound (29 patients) and a subgroup who were taking a "high dose" of oxycodone compound (13 patients) were compared with a group of 171 non-users of oxycodone compound." | 3.66 | Problems with the use of oxycodone compound in patients with chronic pain. ( Maruta, T; Swanson, DW, 1981) |
| "Repaglinide is a novel insulin secretagogue developed in response to the need for a fast-acting, oral prandial glucose regulator for the treatment of type 2 (non-insulin-dependent) diabetes mellitus." | 2.69 | Single-dose pharmacokinetics of repaglinide in subjects with chronic liver disease. ( Christensen, MS; Hatorp, V; Haug-Pihale, G; Walther, KH, 2000) |
| "The patients with liver cirrhosis were classified according to the Child--Pugh scoring system." | 2.68 | [Diagnostic value of the study of caffeine elimination in chronic liver diseases]. ( Bariska, J; Darnót, G; Nemesánszky, E, 1995) |
| "Many of cancers are caused by lifestyle elements." | 2.41 | Mechanisms of chronic disease causation by nutritional factors and tobacco products and their prevention by tea polyphenols. ( Chung, FL; Weisburger, JH, 2002) |
| "Caffeine was administered daily in drinking water (0." | 1.51 | Caffeine as a potential arousal enhancer: altered NMDA subunit gene expression without improving cognitive performance in REM sleep deprived rats. ( Cevik, OS; Kocahan, S; Koyuncu, DD; Sahin, L, 2019) |
| "The consequences of chronic insufficient sleep for health remain uncertain." | 1.46 | Decreased alertness due to sleep loss increases pain sensitivity in mice. ( Alexandre, C; Ferreira, A; Latremoliere, A; Miracca, G; Scammell, TE; Woolf, CJ; Yamamoto, M, 2017) |
| "Glucose metabolic changes in CM patients taking different dosage of analgesic during headache-free periods and clear distinctions in several brain regions were observed." | 1.39 | Overuse of paracetamol caffeine aspirin powders affects cerebral glucose metabolism in chronic migraine patients. ( Di, W; Fang, Y; Luo, N; Miao, J; Qi, W; Shi, X; Tao, Y; Xiao, Z; Yi, C; Zhang, A; Zhang, X; Zhu, Y, 2013) |
| " Chronic administration of caffeine in mice (intraperitoneally, 3 mg/kg/day, for 15 days, >12 h before trials) led to an A(1)-mediated enhancement of the CB(1)-dependent acute disruptive effects of THC on a short-term spatial memory task, despite inducing a reduction in cortical and hippocampal CB(1) receptor number and an attenuation of CB(1) coupling with G protein." | 1.37 | Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Δ9-tetrahydrocannabinol on spatial memory. ( Assaife-Lopes, N; Brett, RR; Pratt, JA; Ribeiro, JA; Sebastião, AM; Sousa, VC, 2011) |
| "Caffeine (10 mg/kg) pretreatment with venlfaxine (5 mg/kg) did not produce any significant effect on locomotor activity, immobility period and oxidative damage as compared to their effect per se." | 1.36 | Venlafaxine involves nitric oxide modulatory mechanism in experimental model of chronic behavior despair in mice. ( Garg, R; Gaur, V; Kumar, A; Kumar, P, 2010) |
| "Chronic neuroinflammation is associated with an increase in extracellular levels of glutamate and drugs that limit the effects of glutamate at neuronal receptors have been shown to indirectly reduce the neuroinflammatory response of microglia cells." | 1.36 | Caffeine attenuates lipopolysaccharide-induced neuroinflammation. ( Brothers, HM; Marchalant, Y; Wenk, GL, 2010) |
| "During follow-up, 918 incident cases of type 2 diabetes were documented." | 1.35 | Coffee and tea consumption and risk of type 2 diabetes. ( Beulens, JW; Boer, JM; Grobbee, DE; Spijkerman, A; Uiterwaal, CS; van der A, DL; van der Schouw, YT; van Dieren, S, 2009) |
| "Overuse of IPC combination in chronic headache patients is associated with increased plasma levels of indomethacin and caffeine, and with delayed elimination of indomethacin; the high and sustained concentrations of these drugs may cause rebound headache, organ damages, and perpetuate medication-overuse headache." | 1.33 | Effect of overuse of the antimigraine combination of indomethacin, prochlorperazine and caffeine (IPC) on the disposition of its components in chronic headache patients. ( Bertolini, A; Coccia, CP; Ferrari, A; Gallesi, D; Leone, S; Loi, M; Pasciullo, G; Pinetti, D; Sances, G; Savino, G; Sternieri, E, 2006) |
| "Although some women with insomnia limit or refrain from caffeine and alcohol intake, many have not optimized behaviors believed to help prevent or modulate insomnia." | 1.32 | Variations in sleep hygiene practices of women with and without insomnia. ( Cheek, RE; Lentz, MJ; Shaver, JL, 2004) |
| "This study attempted to compare the pharmacokinetic parameters of caffeine in patients with chronic liver disease and in normal subjects and to define the two sampling times which are suitable for determining caffeine clearance in these patients." | 1.29 | Caffeine clearance by two point analysis: a measure of liver function in chronic liver disease. ( Israsena, S; Komolmit, P; Thamaree, S; Tongnopnoua, P; Wittayalertpanya, S, 1996) |
| " Caffeine, a member of the methyl-xanthine group, is an interesting molecule in the study of migraine patients because the chronic intake of this substance, contained in numerous analgesics, has been related to the chronic nature of the pain." | 1.28 | [Plasma beta-endorphin and caffeine consumption in chronic hemicrania]. ( Bergamasco, B; De Gennaro, T; Farri, A; Piazza, D; Pinessi, L; Rainero, I; Vaula, G, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 30 (30.93) | 18.7374 |
| 1990's | 19 (19.59) | 18.2507 |
| 2000's | 19 (19.59) | 29.6817 |
| 2010's | 29 (29.90) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexandre, C | 1 |
| Latremoliere, A | 1 |
| Ferreira, A | 1 |
| Miracca, G | 1 |
| Yamamoto, M | 1 |
| Scammell, TE | 1 |
| Woolf, CJ | 1 |
| Acar, E | 1 |
| Gürdeniz, G | 1 |
| Savorani, F | 1 |
| Hansen, L | 1 |
| Olsen, A | 1 |
| Tjønneland, A | 1 |
| Dragsted, LO | 1 |
| Bro, R | 1 |
| Picarillo, AP | 1 |
| Carlo, W | 1 |
| Sanlier, N | 1 |
| Atik, A | 1 |
| Atik, I | 1 |
| Savoia, F | 1 |
| Sechi, A | 1 |
| Tabanelli, M | 1 |
| Zago, S | 1 |
| Leuzzi, M | 1 |
| Baraldi, C | 1 |
| Patrizi, A | 1 |
| Khatri, A | 1 |
| Cheng, L | 1 |
| Camez, A | 1 |
| Ignatenko, S | 1 |
| Pang, Y | 1 |
| Othman, AA | 1 |
| Sahin, L | 1 |
| Cevik, OS | 1 |
| Koyuncu, DD | 1 |
| Kocahan, S | 1 |
| Lopez-Garcia, E | 1 |
| Guallar-Castillon, P | 1 |
| Leon-Muñoz, L | 1 |
| Graciani, A | 1 |
| Rodriguez-Artalejo, F | 1 |
| Ramin, C | 1 |
| Devore, EE | 1 |
| Wang, W | 2 |
| Pierre-Paul, J | 1 |
| Wegrzyn, LR | 1 |
| Schernhammer, ES | 1 |
| Etter, F | 1 |
| Alur, P | 1 |
| Bollampalli, V | 1 |
| Bell, T | 1 |
| Hussain, N | 1 |
| Liss, J | 1 |
| Sacramento, JF | 1 |
| Gonzalez, C | 2 |
| Gonzalez-Martin, MC | 1 |
| Conde, SV | 2 |
| Antoons, G | 1 |
| Johnson, DM | 1 |
| Dries, E | 1 |
| Santiago, DJ | 1 |
| Ozdemir, S | 1 |
| Lenaerts, I | 1 |
| Beekman, JD | 1 |
| Houtman, MJ | 1 |
| Sipido, KR | 1 |
| Vos, MA | 1 |
| Shearer, J | 1 |
| Graham, TE | 1 |
| Skinner, TL | 1 |
| Rosenthal, TC | 1 |
| Majeroni, BA | 1 |
| Pretorius, R | 1 |
| Malik, K | 1 |
| Bigal, ME | 1 |
| Lipton, RB | 2 |
| Scher, AI | 1 |
| Stewart, WF | 1 |
| Bigal, M | 1 |
| Duarte, JM | 1 |
| Carvalho, RA | 1 |
| Cunha, RA | 1 |
| Gruetter, R | 1 |
| van Dieren, S | 1 |
| Uiterwaal, CS | 1 |
| van der Schouw, YT | 1 |
| van der A, DL | 1 |
| Boer, JM | 1 |
| Spijkerman, A | 1 |
| Grobbee, DE | 1 |
| Beulens, JW | 1 |
| Kumar, A | 1 |
| Garg, R | 1 |
| Gaur, V | 1 |
| Kumar, P | 1 |
| Kachroo, A | 1 |
| Irizarry, MC | 1 |
| Schwarzschild, MA | 1 |
| Jha, RM | 1 |
| Mithal, A | 1 |
| Malhotra, N | 1 |
| Brown, EM | 1 |
| Brothers, HM | 1 |
| Marchalant, Y | 1 |
| Wenk, GL | 1 |
| Sousa, VC | 1 |
| Assaife-Lopes, N | 1 |
| Ribeiro, JA | 1 |
| Pratt, JA | 1 |
| Brett, RR | 1 |
| Sebastião, AM | 1 |
| Rodríguez de Cossío, A | 1 |
| Rodríguez Sánchez, R | 1 |
| Alonso Moreno, FJ | 1 |
| Voigt, N | 1 |
| Li, N | 1 |
| Wang, Q | 1 |
| Trafford, AW | 1 |
| Abu-Taha, I | 1 |
| Sun, Q | 1 |
| Wieland, T | 1 |
| Ravens, U | 1 |
| Nattel, S | 1 |
| Wehrens, XH | 1 |
| Dobrev, D | 1 |
| Kamchatnov, PR | 1 |
| Bennadji, B | 1 |
| Desramé, J | 1 |
| de Parades, V | 1 |
| Obeso, A | 1 |
| Monteiro, EC | 1 |
| Di, W | 1 |
| Shi, X | 1 |
| Zhu, Y | 1 |
| Tao, Y | 1 |
| Qi, W | 1 |
| Luo, N | 1 |
| Xiao, Z | 1 |
| Yi, C | 1 |
| Miao, J | 1 |
| Zhang, A | 1 |
| Zhang, X | 1 |
| Fang, Y | 1 |
| Sarobo, C | 1 |
| Lacorte, LM | 1 |
| Martins, M | 1 |
| Rinaldi, JC | 1 |
| Moroz, A | 1 |
| Scarano, WR | 1 |
| Delella, FK | 1 |
| Felisbino, SL | 1 |
| Kromann, CB | 1 |
| Nielsen, CT | 1 |
| Schonewille, WJ | 1 |
| Pauvert, O | 1 |
| Bonnet, S | 2 |
| Rousseau, E | 1 |
| Marthan, R | 2 |
| Savineau, JP | 2 |
| Cheek, RE | 1 |
| Shaver, JL | 1 |
| Lentz, MJ | 1 |
| Meyer, L | 1 |
| Caston, J | 1 |
| Scholten, P | 1 |
| van Leerdam, ME | 1 |
| Kuipers, EJ | 1 |
| Baldwin, DN | 1 |
| Pillow, JJ | 1 |
| Stocks, J | 1 |
| Frey, U | 1 |
| Ferrari, A | 1 |
| Savino, G | 1 |
| Gallesi, D | 1 |
| Pinetti, D | 1 |
| Bertolini, A | 1 |
| Sances, G | 1 |
| Coccia, CP | 1 |
| Pasciullo, G | 1 |
| Leone, S | 1 |
| Loi, M | 1 |
| Sternieri, E | 1 |
| Bonnet, M | 1 |
| Back, SA | 1 |
| Craig, A | 1 |
| Luo, NL | 1 |
| Ren, J | 1 |
| Akundi, RS | 1 |
| Ribeiro, I | 1 |
| Rivkees, SA | 1 |
| Molkara, AM | 1 |
| Abou-Zamzam, AM | 1 |
| Teruya, TH | 1 |
| Bianchi, C | 1 |
| Killeen, JD | 1 |
| Derbyshire, E | 1 |
| Abdula, S | 1 |
| Gushanskiĭ, EL | 1 |
| Baker, AL | 1 |
| Kotake, AN | 1 |
| Schoeller, DA | 1 |
| Bennett, WM | 1 |
| Walker, RG | 1 |
| Henry, JP | 1 |
| Kincaid-Smith, P | 2 |
| Seltzer, S | 1 |
| Rosenberg, L | 1 |
| Slone, D | 1 |
| Shapiro, S | 1 |
| Kaufman, DW | 1 |
| Miettinen, OS | 1 |
| Maruta, T | 1 |
| Swanson, DW | 1 |
| Rodopoulos, N | 1 |
| Wisén, O | 1 |
| Norman, A | 1 |
| Kamimori, GH | 1 |
| Hoyt, RW | 1 |
| Eddington, ND | 1 |
| Young, PM | 1 |
| Durkot, MJ | 1 |
| Forte, VA | 1 |
| Brunhart, AE | 1 |
| Lugo, S | 1 |
| Cymerman, A | 1 |
| Baker, A | 1 |
| Girling, A | 1 |
| Worthington, D | 1 |
| Ballantine, N | 1 |
| Smith, S | 1 |
| Tarlow, M | 1 |
| Kelly, D | 1 |
| Darnót, G | 1 |
| Nemesánszky, E | 1 |
| Bariska, J | 1 |
| Mauskop, A | 1 |
| Altura, BT | 1 |
| Cracco, RQ | 1 |
| Altura, BM | 1 |
| Currie, SR | 1 |
| Wilson, KG | 1 |
| Gauthier, ST | 1 |
| Richardson, NJ | 1 |
| Rogers, PJ | 1 |
| Elliman, NA | 1 |
| O'Dell, RJ | 1 |
| Flaherty, KR | 1 |
| Bates, JR | 1 |
| Sheetz, DA | 1 |
| Iñiguez, C | 1 |
| Larrodé, P | 1 |
| Mauri, JA | 1 |
| Morales, F | 1 |
| Wittayalertpanya, S | 1 |
| Israsena, S | 1 |
| Thamaree, S | 1 |
| Tongnopnoua, P | 1 |
| Komolmit, P | 1 |
| James, JE | 1 |
| Pal'chun, VT | 1 |
| Kriukov, AI | 1 |
| Ogorodnikov, DS | 1 |
| Uzdennikov, AA | 1 |
| Kunel'skaia, NL | 1 |
| Vladimirova, VV | 1 |
| Pintér, I | 1 |
| Nagy, J | 1 |
| Feikema, WJ | 1 |
| Hatorp, V | 1 |
| Walther, KH | 1 |
| Christensen, MS | 1 |
| Haug-Pihale, G | 1 |
| Garcia, GD | 1 |
| Goff, JM | 1 |
| Hadro, NC | 1 |
| O'donnell, SD | 1 |
| Greatorex, PS | 1 |
| Belus, A | 1 |
| Hyvelin, JM | 1 |
| Roux, E | 1 |
| Weisburger, JH | 1 |
| Chung, FL | 1 |
| Rotrosen, J | 1 |
| Miller, AD | 1 |
| Mandio, D | 1 |
| Traficante, LJ | 1 |
| Gershon, S | 1 |
| Bengtsson, U | 1 |
| De Freitas, B | 1 |
| Schwartz, G | 1 |
| Vogl, P | 1 |
| Bonnet, MH | 1 |
| Arand, DL | 1 |
| Sandler, DP | 1 |
| Burr, FR | 1 |
| Weinberg, CR | 1 |
| Hartleb, M | 1 |
| Nowak, A | 1 |
| Becker, A | 1 |
| Mańczyk, I | 1 |
| Pinessi, L | 1 |
| Piazza, D | 1 |
| Vaula, G | 1 |
| Rainero, I | 1 |
| De Gennaro, T | 1 |
| Bergamasco, B | 1 |
| Farri, A | 1 |
| Koczapski, A | 1 |
| Paredes, J | 1 |
| Kogan, C | 1 |
| Ledwidge, B | 1 |
| Higenbottam, J | 1 |
| Hoeldtke, RD | 1 |
| O'Dorisio, TM | 1 |
| Boden, G | 1 |
| Kromann-Andersen, H | 1 |
| Elsborg, L | 1 |
| Friedman, AP | 1 |
| DiSerio, FJ | 1 |
| Scott, NR | 1 |
| Stambuk, D | 1 |
| Chakraborty, J | 1 |
| Marks, V | 1 |
| Morgan, MY | 1 |
| Benson, JI | 1 |
| David, JJ | 1 |
| Breier, A | 1 |
| Charney, DS | 1 |
| Heninger, GR | 1 |
| Walsh, JK | 1 |
| Sugerman, JL | 1 |
| Chambers, GW | 1 |
| Piters, KM | 1 |
| Colombo, A | 1 |
| Olson, HG | 1 |
| Butman, SM | 1 |
| Wahlländer, A | 1 |
| Renner, E | 1 |
| Preisig, R | 1 |
| Hickey, RJ | 1 |
| Clelland, RC | 1 |
| Harner, EB | 1 |
| Boyce, DE | 1 |
| Paramelle, B | 1 |
| Perdrix, A | 1 |
| Nanra, RS | 1 |
| Nechiporuk, VM | 1 |
| Kazakov, VN | 1 |
| Nakhilc, ZSh | 1 |
| MacDonald, WC | 1 |
| Panchenko, EN | 1 |
| Anderson, W | 1 |
| Hollins, JG | 1 |
| Bond, PS | 1 |
| Graeber, W | 1 |
| Drtil, J | 1 |
| Sandz, Z | 1 |
| Wendt, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Multiple Subcutaneous Doses of Risankizumab on the Single Dose Pharmacokinetics of Cytochrome P450 Substrates (Caffeine, Warfarin, Omeprazole, Metoprolol and Midazolam) Administered Orally in an Open-label, One-sequence Trial in Patients Wit[NCT02772601] | Phase 1 | 21 participants (Actual) | Interventional | 2016-09-15 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
14 reviews available for caffeine and Chronic Illness
| Article | Year |
|---|---|
Using Quality Improvement Tools to Reduce Chronic Lung Disease.
Topics: Adrenal Cortex Hormones; Bronchopulmonary Dysplasia; Caffeine; Chronic Disease; Continuous Positive | 2017 |
Consumption of green coffee and the risk of chronic diseases.
Topics: Caffeine; Cardiovascular Diseases; Chlorogenic Acid; Chronic Disease; Coffee; Humans; Phenols | 2019 |
[How much coffee is healthy?].
Topics: Caffeine; Cause of Death; Chronic Disease; Coffee; Dose-Response Relationship, Drug; Humans; Mortali | 2014 |
Nutra-ergonomics: influence of nutrition on physical employment standards and the health of workers.
Topics: Amino Acids; Beverages; Caffeine; Chronic Disease; Diet, Healthy; Dietary Proteins; Employment; Ergo | 2016 |
Fatigue: an overview.
Topics: Behavior Therapy; Benzhydryl Compounds; Caffeine; Central Nervous System Stimulants; Chronic Disease | 2008 |
What predicts the change from episodic to chronic migraine?
Topics: Analgesics; Caffeine; Central Nervous System Stimulants; Chronic Disease; Clinical Trials as Topic; | 2009 |
Lung-function tests in neonates and infants with chronic lung disease: tidal breathing and respiratory control.
Topics: Adult; Animals; Caffeine; Central Nervous System Stimulants; Chemoreceptor Cells; Chronic Disease; F | 2006 |
Clinical utility of breath tests for the assessment of hepatic function.
Topics: Aminopyrine; Breath Tests; Caffeine; Chemical and Drug Induced Liver Injury; Chronic Disease; Cytoch | 1983 |
Foods, and food and drug combinations, responsible for head and neck pain.
Topics: Adult; Alcoholic Beverages; Amygdalin; Cacao; Caffeine; Child; Chronic Disease; Cluster Headache; Dr | 1982 |
[Analgesic nephropathy].
Topics: Analgesics; Caffeine; Chronic Disease; Codeine; Humans; Kidney Diseases; Kidney Neoplasms; Kidney Pa | 1998 |
[Headache and chronic sleep deprivation: an often missed relationship in children and also in adults].
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Caffeine; Central Nervous System Stimulants; Child; Ch | 1999 |
Mechanisms of chronic disease causation by nutritional factors and tobacco products and their prevention by tea polyphenols.
Topics: Animals; Antioxidants; Caffeine; Carcinogens; Chronic Disease; Diet; Digestive System; Enzyme Induct | 2002 |
Prevention of renal disease.
Topics: Anti-Glomerular Basement Membrane Disease; Antipyrine; Caffeine; Chronic Disease; Female; Glomerulon | 1979 |
Chronic effect of analgesics on the kidney.
Topics: Aminopyrine; Analgesics; Animals; Antipyrine; Aspirin; Caffeine; Chronic Disease; Drug Combinations; | 1972 |
10 trials available for caffeine and Chronic Illness
| Article | Year |
|---|---|
Lack of Effect of 12-Week Treatment with Risankizumab on the Pharmacokinetics of Cytochrome P450 Probe Substrates in Patients with Moderate to Severe Chronic Plaque Psoriasis.
Topics: Antibodies, Monoclonal; Area Under Curve; Caffeine; Chronic Disease; Cytochrome P-450 Enzyme System; | 2019 |
[The use of vasobral in patients with chronic cerebrovascular disorders].
Topics: Adult; Aged; Caffeine; Cerebrovascular Disorders; Chronic Disease; Dihydroergotoxine; Drug Combinati | 2011 |
[Diagnostic value of the study of caffeine elimination in chronic liver diseases].
Topics: Administration, Oral; Caffeine; Chronic Disease; Female; Gastrointestinal Transit; Hepatitis, Alcoho | 1995 |
Mood and performance effects of caffeine in relation to acute and chronic caffeine deprivation.
Topics: Acute Disease; Adolescent; Adult; Affect; Anger; Caffeine; Central Nervous System Stimulants; Chroni | 1995 |
Acute and chronic effects of caffeine on performance, mood, headache, and sleep.
Topics: Acute Disease; Affect; Analysis of Variance; Caffeine; Chi-Square Distribution; Chronic Disease; Cro | 1998 |
Single-dose pharmacokinetics of repaglinide in subjects with chronic liver disease.
Topics: Adult; Blood Glucose; Blood Proteins; Caffeine; Carbamates; Chronic Disease; Humans; Hypoglycemic Ag | 2000 |
Caffeine use as a model of acute and chronic insomnia.
Topics: Acute Disease; Adolescent; Adult; Arousal; Attention; Caffeine; Chronic Disease; Circadian Rhythm; D | 1992 |
Treatment of autonomic neuropathy with a somatostatin analogue SMS-201-995.
Topics: Adult; Aged; Autonomic Nervous System Diseases; Blood Pressure; Caffeine; Chronic Disease; Female; H | 1986 |
Symptomatic treatment of chronically recurring tension headache: a placebo-controlled, multicenter investigation of Fioricet and acetaminophen with codeine.
Topics: Acetaminophen; Adult; Barbiturates; Caffeine; Chronic Disease; Clinical Trials as Topic; Consumer Be | 1987 |
Effect of coffee on exercise-induced angina pectoris due to coronary artery disease in habitual coffee drinkers.
Topics: Adult; Aged; Angina Pectoris; Caffeine; Chronic Disease; Coffee; Coronary Disease; Drinking Behavior | 1985 |
73 other studies available for caffeine and Chronic Illness
| Article | Year |
|---|---|
Decreased alertness due to sleep loss increases pain sensitivity in mice.
Topics: Acute Disease; Analgesics; Animals; Behavior, Animal; Benzhydryl Compounds; Caffeine; Chronic Diseas | 2017 |
Forecasting Chronic Diseases Using Data Fusion.
Topics: Acute Coronary Syndrome; Biomarkers; Breast Neoplasms; Caffeine; Chromatography, Liquid; Chronic Dis | 2017 |
Multiple perianal ulcers due to suppositories.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anus Diseases; Caffeine; Central Nervous System Stimu | 2019 |
Caffeine as a potential arousal enhancer: altered NMDA subunit gene expression without improving cognitive performance in REM sleep deprived rats.
Topics: Animals; Arousal; Caffeine; Chronic Disease; Cognition; Gene Expression Regulation; Maze Learning; M | 2019 |
Coffee consumption and health-related quality of life.
Topics: Adolescent; Adult; Aged; Caffeine; Chronic Disease; Coffee; Cross-Sectional Studies; Feeding Behavio | 2014 |
Health tips. Stopping postnasal drip.
Topics: Allergens; Caffeine; Chronic Disease; Cough; Drinking; Gastroesophageal Reflux; Humans; Mucus; Nasal | 2013 |
Night shift work at specific age ranges and chronic disease risk factors.
Topics: Adult; Age Factors; Body Mass Index; Caffeine; Cardiovascular Diseases; Chronic Disease; Energy Inta | 2015 |
Serum caffeine concentrations and short-term outcomes in premature infants of ⩽29 weeks of gestation.
Topics: Caffeine; Chronic Disease; Gestational Age; Hospital Charges; Humans; Infant, Premature; Length of S | 2015 |
Adenosine Receptor Blockade by Caffeine Inhibits Carotid Sinus Nerve Chemosensory Activity in Chronic Intermittent Hypoxic Animals.
Topics: Animals; Caffeine; Carotid Body; Carotid Sinus; Chronic Disease; Hypoxia; Purinergic P1 Receptor Ant | 2015 |
Calcium release near L-type calcium channels promotes beat-to-beat variability in ventricular myocytes from the chronic AV block dog.
Topics: Action Potentials; Animals; Atrioventricular Block; Caffeine; Calcium; Calcium Channels, L-Type; Cal | 2015 |
Patterns of medication use by chronic and episodic headache sufferers in the general population: results from the frequent headache epidemiology study.
Topics: Adolescent; Adult; Aged; Analgesics; Aspirin; Caffeine; Chronic Disease; Disease Progression; Female | 2010 |
Caffeine consumption attenuates neurochemical modifications in the hippocampus of streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Caffeine; Central Nervous System Stimulants; Chronic Disease; Diabetes Melli | 2009 |
Coffee and tea consumption and risk of type 2 diabetes.
Topics: Adult; Aged; Blood Pressure; Body Mass Index; Caffeine; Chronic Disease; Coffee; Diabetes Mellitus, | 2009 |
Venlafaxine involves nitric oxide modulatory mechanism in experimental model of chronic behavior despair in mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety; Arginine; Caffeine; Central Nervous Syst | 2010 |
Caffeine protects against combined paraquat and maneb-induced dopaminergic neuron degeneration.
Topics: Animals; Caffeine; Cell Count; Chronic Disease; Disease Models, Animal; Dopamine; Drug Interactions; | 2010 |
Pilot case-control investigation of risk factors for hip fractures in the urban Indian population.
Topics: Activities of Daily Living; Aged; Bone Diseases, Metabolic; Caffeine; Calcium, Dietary; Case-Control | 2010 |
Caffeine attenuates lipopolysaccharide-induced neuroinflammation.
Topics: Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Aging; Animals; Caffeine; Chro | 2010 |
Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Δ9-tetrahydrocannabinol on spatial memory.
Topics: Adenosine A1 Receptor Antagonists; Animals; Caffeine; Chronic Disease; Dronabinol; Hippocampus; Male | 2011 |
[Peripheral ischaemia after chronic ergot poisoning].
Topics: Blood Vessels; Caffeine; Chronic Disease; Drug Combinations; Ergotamine; Ergotism; Female; Humans; I | 2010 |
Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation.
Topics: Action Potentials; Aged; Animals; Atrial Fibrillation; Benzylamines; Biological Transport, Active; C | 2012 |
Migraine and proctitis: what is the link?
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Caffeine; Central Nervous System | 2013 |
Effect of chronic caffeine intake on carotid body catecholamine dynamics in control and chronically hypoxic rats.
Topics: Animals; Caffeine; Carotid Body; Catecholamines; Chronic Disease; Hypoxia; Rats; Rats, Wistar; Recep | 2012 |
Overuse of paracetamol caffeine aspirin powders affects cerebral glucose metabolism in chronic migraine patients.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Br | 2013 |
Chronic caffeine intake increases androgenic stimuli, epithelial cell proliferation and hyperplasia in rat ventral prostate.
Topics: Administration, Oral; Androgens; Animals; Apoptosis; Caffeine; Cell Proliferation; Central Nervous S | 2012 |
A case of cola dependency in a woman with recurrent depression.
Topics: Adult; Caffeine; Carbonated Beverages; Chronic Disease; Cola; Depressive Disorder, Major; Female; Hu | 2012 |
[Chronic daily headaches caused by too much caffeine].
Topics: Adult; Aged; Caffeine; Chronic Disease; Female; Headache; Humans; Male; Substance-Related Disorders | 2002 |
Sildenafil alters calcium signaling and vascular tone in pulmonary arteries from chronically hypoxic rats.
Topics: Angiotensin II; Animals; Caffeine; Calcium; Calcium Signaling; Chronic Disease; Disease Models, Anim | 2004 |
Variations in sleep hygiene practices of women with and without insomnia.
Topics: Adult; Alcohol Drinking; Caffeine; Case-Control Studies; Chronic Disease; Educational Status; Exerci | 2004 |
Repeated stress alters caffeine action on motor coordination in C57Bl6/J male mice.
Topics: Animals; Caffeine; Central Nervous System Stimulants; Chronic Disease; Disease Models, Animal; Dose- | 2005 |
[Chronic diarrhoea: the importance of an accurate medical history].
Topics: Adult; Caffeine; Chronic Disease; Cost-Benefit Analysis; Diarrhea; Dietary Carbohydrates; Female; He | 2006 |
Effect of overuse of the antimigraine combination of indomethacin, prochlorperazine and caffeine (IPC) on the disposition of its components in chronic headache patients.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antipsychotic Agents; Area Under Curve; Caffeine; Central N | 2006 |
Etiology of insomnia.
Topics: Age Factors; Caffeine; Chronic Disease; Humans; Risk Factors; Sleep Initiation and Maintenance Disor | 2006 |
Protective effects of caffeine on chronic hypoxia-induced perinatal white matter injury.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Animals; Animals, Newborn; Asphyxia Neonatorum; Brain; | 2006 |
Chronic ergot toxicity presenting with bilateral external iliac artery dissection and lower extremity rest pain.
Topics: Adult; Angioplasty; Aortic Dissection; Caffeine; Chronic Disease; Drug Combinations; Ergotamine; Erg | 2006 |
Habitual caffeine intake in women of childbearing age.
Topics: Abortion, Habitual; Adolescent; Adult; Caffeine; Chronic Disease; Diet Records; Female; Fertilizatio | 2008 |
[Dynamics of the reactivity and adaptation in the visual and motor analyzers of the cerebral cortex in normal subjects and in catatonic schizophrenia with a prolonged unfavorable course].
Topics: Adaptation, Physiological; Adult; Caffeine; Catatonia; Chronic Disease; Electroencephalography; Huma | 1966 |
Chronic interstitial nephropathy in mice induced by psychosocial stress: potentiation by caffeine.
Topics: Animals; Caffeine; Chronic Disease; Humans; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred CBA; S | 1983 |
Case-control studies on the acute effects of coffee upon the risk of myocardial infarction: problems in the selection of a hospital control series.
Topics: Acute Disease; Adult; Caffeine; Chronic Disease; Coffee; Feeding Behavior; Female; Hospitalization; | 1981 |
Problems with the use of oxycodone compound in patients with chronic pain.
Topics: Aspirin; Caffeine; Chronic Disease; Codeine; Dextropropoxyphene; Drug Combinations; Female; Humans; | 1981 |
Caffeine metabolism in patients with chronic liver disease.
Topics: Adult; Aged; Biotransformation; Caffeine; Carbon Radioisotopes; Chromatography, High Pressure Liquid | 1995 |
Effects of chronic hypoxia on the pharmacokinetics of caffeine and cardio-green in micro swine.
Topics: Altitude; Animals; Caffeine; Chronic Disease; Disease Models, Animal; Female; Hypoxia; Indocyanine G | 1995 |
The prognostic significance of caffeine half-life in saliva in children with chronic liver disease.
Topics: Adolescent; Aspartate Aminotransferases; Bilirubin; Caffeine; Case-Control Studies; Child; Child, Pr | 1995 |
Chronic daily headache--one disease or two? Diagnostic role of serum ionized magnesium.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Caffeine; Chronic Disease; Diagnosis, Differential; Fema | 1994 |
Caffeine and chronic low back pain.
Topics: Adult; Back Pain; Caffeine; Chronic Disease; Coffee; Disability Evaluation; Drinking; Female; Humans | 1995 |
Mitral regurgitation caused by chronic ergotamine use.
Topics: Adult; Caffeine; Chronic Disease; Drug Combinations; Ergotamine; Ergotism; Female; Humans; Migraine | 1996 |
Caffeine and chronic back pain.
Topics: Adaptation, Psychological; Caffeine; Chronic Disease; Humans; Low Back Pain | 1997 |
[Clinical features of daily chronic headache].
Topics: Acetaminophen; Adult; Age of Onset; Analgesics; Benzodiazepines; Caffeine; Chronic Disease; Ergotami | 1997 |
Caffeine clearance by two point analysis: a measure of liver function in chronic liver disease.
Topics: Adult; Aged; Caffeine; Chronic Disease; Female; Hepatitis; Humans; Liver; Liver Cirrhosis; Liver Dis | 1996 |
[On postop strategies in surgically treated forms of ethmoid sinusitis].
Topics: Acetaminophen; Adult; Aged; Analgesics; Analgesics, Non-Narcotic; Caffeine; Chronic Disease; Codeine | 1998 |
Chronic ergot toxicity: A rare cause of lower extremity ischemia.
Topics: Adult; Caffeine; Chronic Disease; Cyclizine; Drug Combinations; Ergotamine; Ergotism; Female; Foot U | 2000 |
Effect of chronic hypoxia on agonist-induced tone and calcium signaling in rat pulmonary artery.
Topics: Adenosine Triphosphate; Angiotensin II; Animals; Caffeine; Calcium; Calcium Signaling; Chronic Disea | 2001 |
Reduced PGE1 stimulated 3H-cAMP accumulation in platelets from schizophrenics.
Topics: Acute Disease; Adult; Blood Platelets; Caffeine; Chronic Disease; Cyclic AMP; Humans; In Vitro Techn | 1978 |
Effects of caffeine in chronic psychiatric patients.
Topics: Adult; Bipolar Disorder; Caffeine; Chronic Disease; Humans; Male; Middle Aged; Neurocognitive Disord | 1979 |
[Therapy of chronic headache in daily practice].
Topics: Caffeine; Chronic Disease; Female; Headache; Humans; Male; Procaine | 1975 |
Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease.
Topics: Adult; Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Bias; Caffeine; Case-Control Stud | 1991 |
[Effect of smoking on caffeine elimination by the liver in patients with chronic liver diseases].
Topics: Adolescent; Adult; Aged; Caffeine; Chronic Disease; Fatty Liver, Alcoholic; Hepatitis, Chronic; Huma | 1990 |
[Plasma beta-endorphin and caffeine consumption in chronic hemicrania].
Topics: Administration, Oral; Adult; beta-Endorphin; Caffeine; Chronic Disease; Female; Humans; Male; Middle | 1990 |
Effects of caffeine on behavior of schizophrenic inpatients.
Topics: Caffeine; Chronic Disease; Coffee; Humans; Psychiatric Department, Hospital; Psychiatric Status Rati | 1989 |
[Caffeine poisoning as a cause of chronic diarrhea].
Topics: Caffeine; Chronic Disease; Diarrhea; Female; Humans; Middle Aged | 1988 |
Caffeine clearance and biotransformation in patients with chronic liver disease.
Topics: Adult; Aged; Biotransformation; Caffeine; Chronic Disease; Female; Humans; Liver Cirrhosis; Male; Mi | 1988 |
Coffee eating in chronic schizophrenic patients.
Topics: Adult; Caffeine; Chronic Disease; Eating; Female; Hospitalization; Humans; Male; Middle Aged; Schizo | 1986 |
Agoraphobia with panic attacks. Development, diagnostic stability, and course of illness.
Topics: Adult; Agoraphobia; Alcoholism; Anxiety Disorders; Caffeine; Chronic Disease; Depressive Disorder; D | 1986 |
Evaluation of insomnia.
Topics: Adolescent; Benzodiazepines; Caffeine; Chronic Disease; Ethanol; Humans; Muscle Contraction; Psychop | 1986 |
Fasting plasma caffeine concentration. A guide to the severity of chronic liver disease.
Topics: Adult; Caffeine; Chronic Disease; Fasting; Female; Humans; Liver Cirrhosis; Liver Diseases; Liver Fu | 1985 |
Coffee drinking, smoking, pollution, and cardiovascular disease: a problem of self-selection.
Topics: Biogenic Amines; Blood-Brain Barrier; Brain; Caffeine; Cardiovascular Diseases; Chronic Disease; Cof | 1973 |
[Treatment and surveillance of severe chronic respiratory insufficiency].
Topics: Anti-Bacterial Agents; Breathing Exercises; Bronchodilator Agents; Caffeine; Chronic Disease; Expect | 1973 |
[Clinical electrogastrographic studies in inflammatory diseases of the pancreas].
Topics: Acute Disease; Adult; Caffeine; Chronic Disease; Diagnosis, Differential; Electrophysiology; Female; | 1973 |
Correlation of mucosal histology and aspirin intake in chronic gastric ulcer.
Topics: Adult; Aged; Aspirin; Caffeine; Chronic Disease; Epithelium; Female; Gastric Mucosa; Gastritis; Huma | 1973 |
[Treatment of extrapyramidal hyperkinesis].
Topics: Adolescent; Adult; Ambulatory Care; Basal Ganglia Diseases; Benzimidazoles; Benzyl Compounds; Bromin | 1973 |
The composition of tea infusions examined in relation to the association between mortality and water hardness.
Topics: Caffeine; Calcium; Calcium, Dietary; Chronic Disease; England; Humans; Inositol; Metals; Mortality; | 1971 |
[On the effect of caffeine on intraocular pressure in surgically or conservatively managed simple chronic glaucoma].
Topics: Blood Pressure; Blood Pressure Determination; Caffeine; Chronic Disease; Glaucoma; Humans; Intraocul | 1968 |
[Changes in the gastric mucosa following the use of various antiasthmatics and analgesics-antipyretics].
Topics: Adult; Analgesics; Antipyrine; Barbiturates; Bronchodilator Agents; Caffeine; Chronic Disease; Gastr | 1968 |
[The treatment of bronchial asthma and the combination treatment of acute and chronic bronchial, bronchopulmonary and pulmonary infections with Asthma 23D. An experience report of medical practice during the time period of 5 years].
Topics: Acute Disease; Adult; Aminopyrine; Anti-Bacterial Agents; Antitubercular Agents; Asthma; Atropa bell | 1966 |